Mr Stevenson led one of five discussion groups, all looking at the broad theme of how Scotland can prepare itself for the challenges of cancer up to 2020 and beyond.
Issues, which the groups considered, included how politicians can help the NHS respond to the rising cancer incidence resulting from an ageing population, how they can ensure everyone living in Scotland has equality of access to the appropriate care and treatment and what role patients can play in the development of cancer policy.
Mr Stevenson said:

Chief Executive of Cancer Research UK, Professor Alex Markham, said:
“Cancer Research UK Scotland is really grateful to Stewart for making the time to be with us today. We really value his support and that of so many MSPs who campaign on cancer issues, especially through the Cross Party Group on Cancer in the Scottish Parliament.
“It’s so important that the priorities of Scotland’s diverse cancer community are taken on board and championed by the different parties in advance of next year’s Parliamentary elections. In particular, we hope that our call – supported by our Cancer 2020 petition signed by over 150,000 people from across the UK – for politicians to plan now for future cancer challenges up to 2020 and beyond will be heard. With Stewart’s backing, we’re confident it will be”.
Notes:
The Scotland Against Cancer Conference is a major event in the Scottish cancer community’s calendar. In addition to active support from the influential Cross Party Group on Cancer in the Scottish Parliament, it had an impressive line-up of keynote speakers. These included Andy Kerr MSP, Minister for Health and Community Care, and Sir David Carter, Chairman of the Health Foundation & Trustee of Cancer Research UK. MSPs from all parties also contributed to the day.
Cancer Research UK Scotland will use the Conference’s recommendations to help inform its own manifesto for the election. This will be published in the New Year and circulated widely to the different political parties.
Cancer Research UK Scotland is very grateful to Gold Sponsors, Scottish Cancer Industry Group of the ABPI, and Silver Sponsors, Bayer HealthCare; GlaxoSmithKline; Lilly; Merck; Novartis Oncology; Ortho Biotech; Roche and Sanofi Aventis, for their support, without which the Scotland Against Cancer Conference would not be possible.
Cancer Research UK Scotland is also very grateful to Cancerbackup Scotland, Macmillan Cancer Support, Myeloma UK, Scottish Cancer Industry Group of the ABPI and Scottish Partnership for Palliative Care for their help in organising the conference programme.
Categories [Health and Community Care]